Millennium Pharmaceuticals Inc.

Cambridge, MA, United States

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Millennium Pharmaceuticals Inc.

FDA Drug Class II Terminated

VELCADE (bortezomib) for injection, 3.5 mg/vial, Reconstitution Information, SUBCUTANEOUS INJECTION ONLY add 1.4 mL 0.9% Sodium Chloride to make 2.5 mg/ mL final concentration, INTRAVENOUS INJECTION O

January 30, 2018 Millennium Pharmaceuticals Inc. 154,372 vials units